ARTICLE | Company News
Epigenomics, Quest Diagnostics deal
March 2, 2009 8:00 AM UTC
Quest received a non-exclusive, U.S. license to develop and commercialize Epigenomics' glutathione S-transferase P1 (GST P1) methylation biomarker in molecular tissue-based laboratory developed tests...